Perrigo Income Taxes 2010-2025 | PRGO
Perrigo income taxes from 2010 to 2025. Income taxes can be defined as the total amount of income tax expense for the given period.
| Perrigo Annual Income Taxes (Millions of US $) |
|
|---|---|
| 2024 | $80 |
| 2023 | $-4 |
| 2022 | $-8 |
| 2021 | $390 |
| 2020 | $-38 |
| 2019 | $-11 |
| 2018 | $160 |
| 2017 | $161 |
| 2016 | $-836 |
| 2015 | $-34 |
| 2015 | $124 |
| 2014 | $71 |
| 2013 | $166 |
| 2012 | $119 |
| 2011 | $110 |
| 2010 | $84 |
| 2009 | $63 |
| Perrigo Quarterly Income Taxes (Millions of US $) |
|
|---|---|
| 2025-03-31 | $8 |
| 2024-12-31 | $112 |
| 2024-09-30 | $39 |
| 2024-06-30 | $32 |
| 2024-03-31 | $-103 |
| 2023-12-31 | $-27 |
| 2023-09-30 | $4 |
| 2023-06-30 | $14 |
| 2023-03-31 | $5 |
| 2022-12-31 | $-2 |
| 2022-09-30 | $49 |
| 2022-06-30 | $-43 |
| 2022-03-31 | $-12 |
| 2021-12-31 | $-22 |
| 2021-09-30 | $443 |
| 2021-06-30 | $-45 |
| 2021-03-31 | $14 |
| 2020-12-31 | $-63 |
| 2020-09-30 | $22 |
| 2020-06-30 | $3 |
| 2020-03-31 | $0 |
| 2019-12-31 | $-51 |
| 2019-09-30 | $5 |
| 2019-06-30 | $18 |
| 2019-03-31 | $17 |
| 2018-12-31 | $122 |
| 2018-09-30 | $-12 |
| 2018-06-30 | $19 |
| 2018-03-31 | $30 |
| 2017-12-31 | $59 |
| 2017-09-30 | $84 |
| 2017-06-30 | $-7 |
| 2017-03-31 | $24 |
| 2016-12-31 | $-285 |
| 2016-09-30 | $-312 |
| 2016-06-30 | $-278 |
| 2016-03-31 | $39 |
| 2015-12-31 | $-162 |
| 2015-09-30 | $34 |
| 2015-06-30 | $83 |
| 2015-03-31 | $12 |
| 2014-12-31 | $15 |
| 2014-09-30 | $12 |
| 2014-06-30 | |
| 2014-03-31 | $15 |
| 2013-12-31 | $-27 |
| 2013-09-30 | $46 |
| 2013-06-30 | |
| 2013-03-31 | $48 |
| 2012-12-31 | $40 |
| 2012-09-30 | $35 |
| 2012-06-30 | |
| 2012-03-31 | $19 |
| 2011-12-31 | $45 |
| 2011-09-30 | $18 |
| 2011-06-30 | |
| 2011-03-31 | $21 |
| 2010-12-31 | $32 |
| 2010-09-30 | $29 |
| 2010-06-30 | |
| 2010-03-31 | $23 |
| 2009-12-31 | $31 |
| 2009-09-30 | $14 |
| 2009-06-30 | |
| 2009-03-31 | $17 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $3.660B | $4.373B |
| Perrigo Co. plc, with a diversified revenue stream, sells infant formulas for the store brand market, generic extended topical prescription (Rx) products and specialty pharmaceutical drugs. It's focusing on self-care products as part of its transformation into a self-care company from a healthcare company. The company divested its Rx segment to Altaris Capital Partners. The company completed its transformation to a consumer self-care company by reconfiguring the portfolio through the divestiture of RX business. Currently, the company has 2 reporting segments. Consumer Self Care Americas (CSCA): The segment comprises the U.S., Mexico and Canada CHC business, including OTC, contract manufacturing, infant formula and animal health categories. Consumer Self Care International?(CSCI): The segment comprises the branded consumer healthcare (BCH) segment mainly in Europe and the company's consumer-focused businesses in the UK and Australia. This segment includes UK liquids licensed products business. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $239.054B | 28.75 |
| Boston Scientific (BSX) | United States | $154.291B | 38.63 |
| Stryker (SYK) | United States | $149.710B | 31.30 |
| EssilorLuxottica (ESLOY) | France | $128.407B | 0.00 |
| Medtronic (MDT) | Ireland | $110.260B | 15.63 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.622B | 0.00 |
| Haleon (HLN) | United Kingdom | $47.216B | 26.92 |
| ResMed (RMD) | United States | $37.817B | 28.40 |
| Agilent Technologies (A) | United States | $33.696B | 21.97 |
| GE HealthCare Technologies (GEHC) | United States | $33.311B | 15.81 |
| Terumo (TRUMY) | Japan | $27.198B | 35.33 |
| Koninklijke Philips (PHG) | Netherlands | $23.033B | 16.16 |
| Insulet (PODD) | United States | $21.551B | 84.59 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.358B | 11.79 |
| Baxter (BAX) | United States | $15.708B | 11.73 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.095B | 0.00 |
| Demant (WILYY) | Denmark | $9.110B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.558B | 22.82 |
| Lantheus Holdings (LNTH) | United States | $5.573B | 14.06 |
| Prestige Consumer Healthcare (PBH) | United States | $4.039B | 18.04 |
| Haemonetics (HAE) | United States | $3.526B | 16.06 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.280B | 27.25 |
| ICU Medical (ICUI) | United States | $3.251B | 23.97 |
| GN Store Nord (GNNDY) | Denmark | $2.346B | 19.43 |
| LeMaitre Vascular (LMAT) | United States | $1.910B | 42.70 |
| QuidelOrtho (QDEL) | United States | $1.901B | 13.07 |
| AtriCure (ATRC) | United States | $1.598B | 0.00 |
| Acuren (TIC) | United States | $1.263B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.216B | 12.34 |
| Green Thumb Industries (GTBIF) | United States | $1.111B | 25.00 |
| Neogen (NEOG) | United States | $1.057B | 13.53 |
| BioLife Solutions (BLFS) | United States | $1.015B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.003B | 12.82 |
| Kestra Medical Technologies (KMTS) | United States | $0.908B | 0.00 |
| InMode (INMD) | Israel | $0.898B | 9.05 |
| CeriBell (CBLL) | United States | $0.698B | 0.00 |
| Owens & Minor (OMI) | United States | $0.607B | 5.04 |
| Evolus (EOLS) | United States | $0.587B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.578B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.557B | 0.00 |
| Valneva SE (VALN) | France | $0.468B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.459B | 0.00 |
| Surmodics (SRDX) | United States | $0.413B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.396B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.335B | 12.32 |
| SNDL (SNDL) | Canada | $0.321B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.301B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.281B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.276B | 23.27 |
| Cerus (CERS) | United States | $0.252B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.250B | 0.00 |
| ZimVie (ZIMV) | United States | $0.250B | 11.34 |
| Sanara MedTech (SMTI) | United States | $0.249B | 0.00 |
| Quanterix (QTRX) | United States | $0.241B | 0.00 |
| Brainsway (BWAY) | Israel | $0.233B | 61.65 |
| Biote (BTMD) | United States | $0.227B | 6.37 |
| Canopy Growth (CGC) | Canada | $0.226B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.220B | 65.33 |
| OraSure Technologies (OSUR) | United States | $0.215B | 0.00 |
| Omeros (OMER) | United States | $0.205B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.197B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.181B | 14.71 |
| High Tide (HITI) | Canada | $0.178B | 0.00 |
| Organigram Global (OGI) | Canada | $0.177B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.175B | 0.00 |
| Exagen (XGN) | United States | $0.144B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.138B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.120B | 14.81 |
| Jin Medical (ZJYL) | China | $0.108B | 0.00 |
| Veru (VERU) | United States | $0.102B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.089B | 0.00 |
| Fonar (FONR) | United States | $0.088B | 11.32 |
| Quipt Home Medical (QIPT) | United States | $0.084B | 0.00 |
| MacroGenics (MGNX) | United States | $0.083B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.078B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.075B | 0.00 |
| Zynex (ZYXI) | United States | $0.074B | 0.00 |
| Apyx Medical (APYX) | United States | $0.072B | 0.00 |
| InterCure (INCR) | Israel | $0.067B | 0.00 |
| Agape ATP (ATPC) | $0.063B | 0.00 | |
| Jushi Holdings (JUSHF) | United States | $0.061B | 0.00 |
| ImmuCell (ICCC) | United States | $0.055B | 0.00 |
| Nephros (NEPH) | United States | $0.045B | 59.98 |
| Modular Medical (MODD) | United States | $0.044B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 13.25 |
| Rockwell Medical (RMTI) | United States | $0.028B | 0.00 |
| Safety Shot (SHOT) | United States | $0.023B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.014B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| Senestech (SNES) | United States | $0.007B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |